Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Which painkiller is best after keyhole lung surgery? new study aims to find out

NCT ID NCT07238348

First seen Nov 20, 2025 · Last updated Jun 23, 2026 · Updated 30 times

Summary

This study will observe 120 adults undergoing video-assisted thoracoscopic surgery (VATS) to compare three pain management approaches: a nerve block (SPSIPB), an epidural, and standard opioid painkillers. Researchers will measure pain scores and how much extra pain medicine patients need in the first 24 hours after surgery. The goal is to identify which method provides the best pain relief with the fewest side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN MANAGEMENT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Serratus Posterior Superior Intercostal Plane Block (SPSIPB), Thoracic Epidural Analgesia (TEA), systemic opioid analgesia

What this could lead to

If this study succeeds, it could point to a better, safer way to manage pain after minimally invasive lung surgery, potentially reducing opioid use and side effects.

What could go wrong

This is an observational study, not a randomized trial, so results may be less definitive. It is also small (120 people) and hasn't started yet, so findings may not apply to all patients.

Conditions

The condition(s) this trial relates to.

agnosia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.